Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Q
Qamar N. - Thrombotic potential may be increased in healthy individuals with a two-generation family history of premature myocardial infarction
Qian H. S. - Overexpression of PAI-1 prevents abdominal aortic aneurysm development
Quagliara D. - Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Quehenberger P. - Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
  - The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
  - Assessing the risk of recurrence in patients with a first spontaneous venous thromboembolism by use of D-dimer
  - The impact of interassay-variations in the International Normalized Ratio on dosing oral anti-coagulants
  - IgG-antibodies (IgG-Ab) against beta-2-glycoprotein I (b2-GPI) are associated with an increased risk for thrombotic events (TE) in patients (pts) with the lupus anticoagulant (LA)
Quek S. - Patterns of cases and impact of venous thromboembolism (VTE) in a tertiary institution in Singapore: defying notions of VTE as a disorder of lower significance among Asians
Quenet S. - Factors predicting venous thrombotic complications after superficial–vein thrombosis
Quenet S. - Differences between predictive factors for PE and DVT recurrences: results from 5 randomized trials
  - Risk factors of major hemorrhages during treatment of acute DVT: results from 5 randomized trials
  - Predictive factors of cancer discovery after deep-vein thrombosis: a 8-years follow-up study
Quéré I. - Anti-protein Z antibodies in women with abnormal pregnancies
  - Antiphospholipid/antiprotein antibodies and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case–control study
  - Effect of hyperhomocysteinemia on paraoxonase activity
Quignon V. - A modified ELISA procedure for platelet factor 4 with decreased heparin sensitivity
Quinlan D. J. - Low-molecular-weight heparin is as effective and safe as unfractionated heparin for the initial treatment of pulmonary embolism: a meta-analysis
Quinlan D. J. - Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
Quinn-Allen M. A. - Tyr1956 and Leu1957 in the factor V C1-domain are required for high affinity binding of factor Va to phospholipid membranes
  - Identification of the multimerin binding region within the C2 domain of human factor V using constructs generated by alanine scanning and site-directed mutagenesis
  - Trp2063 and Trp2064 in the factor V C2 domain are required for factor Va binding to phospholipid membranes but not for assembly of the prothrombinase complex
  - A phosphatidylserine binding site distinct from the C2 domain membrane attachment site regulates the assembly and activity of the human prothrombinase
Quint J. - Thrombophilia does not increase the risk for neonatal complications in preterm infants
Quintavalla R. - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Quintavalla R. - Inferior vena cava filters: personal experience on 322 devices, with regard also to medical treatment during long-term follow-up
Quintavalla R. - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Quinton T. M. - Specificity and redundancy of G-protein pathways in agonist-induced alpha granule release in human platelets
  - Stimulation of PAR-1 does not lead to G protein redistribution in human platelets
Quinton T. - Plasmin-mediated activation of platelets occurs through interaction with PAR-4
Quintvilla R. - Guidelines on management of nontherapeutic INRs: are really easy to apply in daily practice?
Quiroga T. - Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Quiroga T. - Lack of association of platelet membrane glycoprotein polymorphisms with the clinical expression of von Willebrand disease type 1
  - Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Qurashi F. - Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies